{Reference Type}: Case Reports
{Title}: Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report.
{Author}: Vita S;D'Abramo A;Coppola A;Farroni C;Iori AP;Faraglia F;Sette A;Grifoni A;Lindestam Arlehamn C;Bibas M;Goletti D;Nicastri E;
{Journal}: Front Oncol
{Volume}: 14
{Issue}: 0
{Year}: 2024
{Factor}: 5.738
{DOI}: 10.3389/fonc.2024.1290614
{Abstract}: Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy.